Does 'andropause' exist, and can TRT fix it?

What's this video probably claiming?

Based on the caption and hashtags, this pharmacist is likely walking viewers through a list of symptoms, framing them under the term "andropause," and drawing a parallel to menopause in women. The implied message: testosterone naturally craters as men age, that decline causes erectile dysfunction, fatigue, mood changes, anxiety, and low libido, and treatment options exist that mirror HRT for women. The hashtag use of both "andropause" and "trt" suggests the video probably positions testosterone replacement therapy as the logical intervention. That framing is popular on TikTok. It's also, in important ways, an oversimplification of what the clinical evidence actually supports.

What does the science actually show?

Testosterone does decline with age, roughly 1-2% per year after age 30, according to longitudinal data from the Massachusetts Male Aging Study (Feldman et al., 2002, Journal of Clinical Endocrinology and Metabolism). But here's where the term "andropause" gets medically contested. Unlike menopause, which represents a near-universal, biologically discrete hormonal event in women, age-related testosterone decline in men is gradual, highly variable, and not universal. The Endocrine Society's 2018 clinical practice guidelines explicitly state that TRT should only be offered to men with symptomatic hypogonadism confirmed by two fasting morning testosterone measurements below approximately 300 ng/dL, not to men with low-normal levels experiencing general aging symptoms. The T Trials (Snyder et al., 2016, NEJM) showed modest sexual function benefits in men 65 and older with confirmed low testosterone, but effects on energy and mood were less convincing.

Where does the social media noise diverge from clinical reality?

The biggest disconnect here is symptom attribution. Fatigue, low libido, mood changes, and anxiety are extraordinarily nonspecific. They map onto depression, sleep apnea, thyroid dysfunction, metabolic syndrome, and a dozen other conditions as readily as they map onto low testosterone. A video that presents these symptoms as signs of "andropause" risks encouraging viewers to self-diagnose and seek TRT before ruling out more treatable, and sometimes more serious, underlying causes. There's also the HRT comparison worth scrutinizing. Menopausal HRT has a large evidence base across decades of trials. The cardiovascular risk profile of TRT in aging men is still being actively studied. The TRAVERSE trial (Lincoff et al., 2023, NEJM) in men with hypogonadism found TRT did not significantly increase major adverse cardiovascular events, which is reassuring, but the follow-up was 33 months and the debate isn't settled for all subgroups.

What should you actually know?

If you're a man in your 40s or 50s and you feel like garbage, that deserves investigation, but the investigation should start with a full workup, not a TRT prescription. Get two fasting morning total testosterone tests. Get your LH and FSH checked to understand whether low levels are primary or secondary. Rule out obstructive sleep apnea, which is a significant and underdiagnosed driver of fatigue and low testosterone. Rule out depression. If your testosterone is genuinely below clinical thresholds and symptoms align, TRT is a legitimate option with real evidence behind it. But starting TRT when your testosterone is low-normal because a TikTok checklist resonated with you is a different situation entirely, and one your prescriber should push back on. The pharmacist here is probably giving broadly reasonable information, but the format encourages symptom-matching in ways that can lead men to seek treatment they may not need.